JP2007526300A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526300A5
JP2007526300A5 JP2007501740A JP2007501740A JP2007526300A5 JP 2007526300 A5 JP2007526300 A5 JP 2007526300A5 JP 2007501740 A JP2007501740 A JP 2007501740A JP 2007501740 A JP2007501740 A JP 2007501740A JP 2007526300 A5 JP2007526300 A5 JP 2007526300A5
Authority
JP
Japan
Prior art keywords
arg
phe
formula
ile
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007501740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2005/000078 external-priority patent/WO2005084715A2/en
Publication of JP2007526300A publication Critical patent/JP2007526300A/ja
Publication of JP2007526300A5 publication Critical patent/JP2007526300A5/ja
Pending legal-status Critical Current

Links

JP2007501740A 2004-03-04 2005-03-03 医薬化合物 Pending JP2007526300A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20040953 2004-03-04
PCT/NO2005/000078 WO2005084715A2 (en) 2004-03-04 2005-03-03 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy

Publications (2)

Publication Number Publication Date
JP2007526300A JP2007526300A (ja) 2007-09-13
JP2007526300A5 true JP2007526300A5 (cg-RX-API-DMAC7.html) 2008-04-17

Family

ID=34918859

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007501740A Pending JP2007526300A (ja) 2004-03-04 2005-03-03 医薬化合物

Country Status (7)

Country Link
US (1) US7763234B2 (cg-RX-API-DMAC7.html)
EP (1) EP1729823B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007526300A (cg-RX-API-DMAC7.html)
CN (1) CN1925876A (cg-RX-API-DMAC7.html)
AT (1) ATE447417T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005017475D1 (cg-RX-API-DMAC7.html)
WO (1) WO2005084715A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
WO2006036071A2 (en) * 2004-09-29 2006-04-06 Ge Healthcare As Urokinase plasminogen activator receptor targeted contrast agent
AU2005307195A1 (en) * 2004-11-22 2006-05-26 Ge Healthcare As Contrast agents to target extracellular matrix
WO2010089757A2 (en) * 2008-11-07 2010-08-12 Usv Limited An improved process for synthesis of cyclic octapeptide
US9730916B2 (en) * 2014-02-27 2017-08-15 Chang Gung Memorial Hospital, Keelung Nutritional composition and method for improving heart failure
EP3759121A1 (en) 2018-03-01 2021-01-06 Trigemina, Inc. Labeled oxytocin and method of manufacture and use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966896A (en) 1974-09-06 1976-06-29 Mallinckrodt, Inc. Radioimmunoassay for plasma renin activity
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4687659A (en) 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
WO1993012819A1 (en) 1992-01-03 1993-07-08 Rhomed Incorporated Protein- and peptide-metal ion pharmaceutical applications
ATE314097T1 (de) * 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
CA2269985A1 (en) 1996-10-28 1998-05-07 Aslak Godal Improvements in or relating to diagnostic/therapeutic agents
US6230777B1 (en) 1999-02-04 2001-05-15 Midmac Systems, Inc. Filter forming and joining apparatus
JP5043271B2 (ja) 2000-04-12 2012-10-10 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
WO2002020610A2 (en) * 2000-09-07 2002-03-14 Biosynthema Inc. Conformationally constrained labeled peptides for imaging and therapy
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
CN1622830A (zh) * 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP5784911B2 (ja) ボンベシンアナログペプチドアンタゴニスト複合体
CN1158133A (zh) 肽衍生的放射性核素螯合剂
ES2395961T3 (es) Composiciones de péptidos radiomarcados para dirigir a un sitio específico
JP2015172080A (ja) 癌の画像化と処置
JP2009537624A5 (cg-RX-API-DMAC7.html)
JP7502801B2 (ja) ガストリン放出ペプチド受容体(grpr)のインビボイメージングおよびgrpr関連障害の治療のための放射性標識ボンベシン由来化合物
JP2954355B2 (ja) 血栓イメージング用の放射性同位体標識化合物
KR20140053819A (ko) 방사선요법용 177루테튬-표지 봄베신 유사체
CA2828655A1 (en) Technetium labelled peptides
JP2011509926A5 (cg-RX-API-DMAC7.html)
JP2014517005A5 (cg-RX-API-DMAC7.html)
US7785566B2 (en) Pharmaceutical compounds
AU2003279444A1 (en) Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
EP0741747A1 (en) Inhibitors of serine proteases, bearing a chelating group
ES2846023T3 (es) Agonistas selectivos del receptor de glucagón que comprenden un resto quelante para formación de imágenes
US7763234B2 (en) Pharmaceutical compounds
Masuda et al. Concise site-specific synthesis of DTPA–peptide conjugates: Application to imaging probes for the chemokine receptor CXCR4
WO2021081430A1 (en) Fibrin-binding compounds for imaging and treatment
HK1192487A (en) 177 lutetium-labeled bombesin analogs for radiotherapy